ArticleCancer medicine2018

Suramin, screened from an approved drug library, inhibits HuR functions and attenuates malignant phenotype of oral cancer cells.

Wataru Kakuguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.